What is Mehran score?

Discrimination. The discriminatory capacity of the Mehran CIN risk score, a measure of its ability to distinguish between patients who will and who will not suffer CIN, was determined by calculating the C-statistic, which is equivalent to the area under the receiver-operating characteristic curve [9].

What is contrast-induced nephropathy?

Contrast-induced nephropathy (CIN) is a serious complication of angiographic procedures resulting from the administration of contrast media (CM). It is the third most common cause of hospital acquired acute renal injury and represents about 12% of the cases.

How is the risk of contrast-induced nephropathy calculated?

What is the scoring system used to identify risk for contrast-induced nephropathy (CIN)?

1. Hypotension = 5 points.
2. Intra-aortic balloon pump (IABP) use = 5 points.
3. CHF = 5 points.
4. SCr >1.5 mg/dL = 4 points.
5. Age >75 years = 4 points.
6. Anemia = 3 points.
7. Diabetes mellitus = 3 points.
8. Contrast volume = 1 point for each 100 mL used.

How is contrast-induced nephropathy diagnosed?

Practice Essentials. Contrast-induced nephropathy (CIN) is defined as the impairment of kidney function—measured as either a 25% increase in serum creatinine (SCr) from baseline or a 0.5 mg/dL (44 µmol/L) increase in absolute SCr value—within 48-72 hours after intravenous contrast administration.

What is CIN risk?

The risk of CIN is elevated and becomes clinically important in patients with chronic kidney disease characterized by an estimated glomerular filtration rate <60 mL/min per 1.73 m(2). In patients with renal impairment, diabetes mellitus amplifies the risk of CIN and complicates postprocedure management.

What is CIN from contrast dye?

What is Contrast Induced Nephropathy (CIN)? CIN is a rare disorder and occurs when kidney problems are caused by the use of certain contrast dyes. In most cases contrast dyes used in tests, such as CT (computerized tomography) and angiograms, have no reported problems.

What are symptoms of contrast-induced nephropathy?

CIN is associated with a sharp decrease in kidney function over a period of 48-72 hours. The symptoms can be similar to those of kidney disease, which include feeling more tired, poor appetite, swelling in the feet and ankles, puffiness around the eyes, or dry and itchy skin.

What is the creatinine cutoff for CT contrast?

The commonly used cutoff, a serum creatinine concentration of 1.5 mg/dL or higher, fails to detect 40% of patients at risk of contrast-induced AKI. The GFR is thought to provide the best overall index of renal function, but measuring it may be impractical.

What GFR is safe for IV contrast?

If eGFR value is greater than 30 the patient can receive IV iodinated contrast. If eGFR is less than or equal to 30 the case will need approval by the radiologist before IV contrast is used to minimize risk of contrast related AKI.

How can you reduce the risk of CIN?

The cornerstone of prevention of CIN is appropriate risk stratification, intravenous hydration with normal saline or sodium bicarbonate, appropriate withholding of nephrotoxic medications, use of low or iso-osmolar contrast media, and various intraprocedural methods for iodinated contrast dose reduction.

What is CIN after CT scan?

CIN is a rare disorder and occurs when kidney problems are caused by the use of certain contrast dyes. In most cases contrast dyes used in tests, such as CT (computerized tomography) and angiograms, have no reported problems. About 2 percent of people receiving dyes can develop CIN.

What is CIN in CKD?

Contrast-induced nephropathy (CIN) is defined as the impairment of renal function, measured through an increase of the serum creatinine (SCr) of more than 44 μmol/L or 25%, following the intravascular administration of a contrast medium (CM) (1).

What should be the creatinine level for CT scan?

Conclusion: The data suggest that the majority of patients with a serum creatinine level of at least 2.0 mg/dL (177 micromol/L) will be identified by screening for risk factors.

How is contrast-induced nephropathy treated?

Contrast-Induced Nephropathy Treatment & Management

1. Approach Considerations.
2. Hydration Therapy.
3. Statins.
4. Bicarbonate Therapy.
5. N-acetylcysteine.
6. Renal Replacement Therapy.
7. Other Therapies.
8. Deterrence and Prevention.

What is GFR cutoff for IV contrast?

What is normal creatinine level for CT scan?

What is the GFR cutoff for CT with contrast?

For CT, eGFR > 45 indicates no increased risk of kidney damage from contrast material. eGFR > 30, but less than 45 indicates that while it is safe to get contrast material, there is a small risk of causing kidney damage.

At what GFR is contrast contraindicated?

Patients with an eGFR lower than 30 mL/min/1.73 m2 are at very high risk of contrast-induced AKI; for these patients, all recommended prophylactic strategies should be used, as guided by a consultant nephrologist, and alternatives to the administration of iodinated contrast medium should be considered.

What is the Mehran score?

Mehran score for prediction of risk of contrast induced AKI (acute kidney injury) in patients undergoing percutaneous coronary intervention was published by Roxana Mehran and associates in 2004 [1]. They randomized data of over eight thousand three hundred patients to development and validation data sets.

What is the akin criteria for diagnosis of contrast-induced nephropathy?

The AKIN criteria states that the diagnosis is made if within 48 hours from intravascular contrast medium exposure one of the following occurs: It is unclear if CIN causes persisting decline in renal function since few studies has followed patients for more than 72 hours.

What is the definition of contrast-induced nephropathy?

In the original study, “contrast-induced nephropathy” was defined as an increase ≥0.5 mg/dL (or ≥25%) in pre-PCI serum creatinine at 48 hours post-PCI. Please fill out required fields.

Is the Mehran risk score valuable for predicting CIN in ACS patients?

Mehran risk score has been validated in our study as a good score for predicting CIN in patients with ACS who underwent coronary angiography. According to this, we support its use in patients hospitalized for ACS in order to identify the ones at risk, and to optimize CIN prophylactic therapy prior t …